To this aim, we performed WGS on 8 primary human glioblastomas (GBM) and matched whole blood and serum cell-free DNA samples, and then compared the estimated rates of ALT-TFs against published cell-free DNA WGS data from healthy controls56 (Methods). This evidence concerns the gene GPT and glioblastoma.